Patient-Centric
Tailored for paediatric, geriatric, and dysphagic patients. Helpful for patients with an active lifestyle, the ease of administration plays a vital role in ensuring treatment success.
Innovative Dosage Technologies for Safer, Easier and Patient-Friendly Administration
InstaPill®’s advanced technology platform from Tenshi Kaizen enables the development of orally disintegrating tablets that eliminate the need for water offering a smoother administration experience for patients who struggle with swallowing including children, older adults and individuals with psychiatric or neurological conditions. The convenience of on-the-go use and our extensive flavour masking capabilities further enhance patient comfort and acceptance.
For healthcare and pharmaceutical partners, InstaPill® delivers a competitive edge through a differentiated delivery format that improves adherence and enables faster market entry. Whether expanding an existing portfolio or exploring new therapeutic segments, our solutions are built to align with regulatory expectations and long-term commercial success.
KNOW MORE
The InstaPill® Advantage
No Water Needed
Dissolves on the tongue with minimal saliva in 3-10 seconds.
Broad Applications
Used for anti-emetics (motion sickness), anti-psychotics (schizophrenia), anti-depressants, anxiolytics, gastro care, antihistamines (allergy treatments) and many more.
Enables Pre-Gastric And Sublingual Absorption
For faster onset and enhanced bioavailability.
Precise Dosage Anytime, Anywhere
Ideal for travel or emergencies.
Taste Masked Formulations
Instapill® offers a wide range of flavour profiles to enhance palatability and elevate the patient experience. By using Vegan, Kosher, Halal and GMO-free formulas, we cater to diverse consumer needs and preferences.
Patient-Centric
Tailored for paediatric, geriatric, and dysphagic patients. Helpful for patients with an active lifestyle, the ease of administration plays a vital role in ensuring treatment success.
Patient-Centric
Tailored for paediatric, geriatric, and dysphagic patients. Helpful for patients with an active lifestyle, the ease of administration plays a vital role in ensuring treatment success.
No Water Needed
Dissolves on the tongue with minimal saliva in 3-10 seconds.
Broad Applications
Used for anti-emetics (motion sickness), anti-psychotics (schizophrenia), anti-depressants, anxiolytics, gastro care, antihistamines (allergy treatments) and many more.
Enables Pre-Gastric And Sublingual Absorption
For faster onset and enhanced bioavailability.
Precise Dosage Anytime, Anywhere
Ideal for travel or emergencies.
Taste Masked Formulations
Instapill® offers a wide range of flavour profiles to enhance palatability and elevate the patient experience. By using Vegan, Kosher, Halal and GMO-free formulas, we cater to diverse consumer needs and preferences.
How it works
InstaPill®’s formulation begins with the development of an aqueous suspension or solution that is precisely dispensed into individual blister cavities for accurate dosing and consistent quality. Containing more than 70% water, this sophisticated suspension or solution undergoes advanced flash freezing followed by lyophilization, skilfully removing the water to create a porous capillary network. This unique design enables the tablet to quickly absorb saliva and disperse almost instantly. As a result, patients grappling with dysphagia experience unmatched convenience and the caregivers can be assured that effective care is provided through the delivery of accurate doses.
Scalable, High Precision Manufacturing for Global Market Readiness
InstaPill® ensures stability with advanced formulation techniques like freeze-drying and taste masking. Our cGMP certified facility in India support seamless scale up across dosage strengths and packaging. With automated lines, serialisation capability, 200 million ODTs annual capacity, we provide a turnkey pharma solution.
Partner with Us
Tenshi Kaizen has the platform technology and taste masking expertise to bring your Target Product Profile ODT from feasibility to market using QbD principles. Tenshi Kaizen currently operates a state-of-the-art facility in Bengaluru with a capacity of 300 million ODTs which is set to scale up to 500 million ODTs.
Our fully automated, integrated line with serialisation and electronic batch records simplifies your supply chain with the highest quality and regulatory compliance standards. We always invest in capacity well-in-advance of requirements so you can trust us to be your turnkey CDMO partner for your next patient-centric medicine.